ERCC4 | Excision repair cross-complementing rodent repair deficiency, complementation group 4 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ERCC5 | Excision repair cross-complementing rodent repair deficiency, complementation group 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EXT1 | Exostosin glycosyltransferase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
EXT2 | Exostosin glycosyltransferase 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
FAM46C | Family with sequence similarity 46, member C | Cancer-related genes
| | | | | Mixed |
FANCA | Fanconi anemia, complementation group A | Cancer-related genes Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
FANCC | Fanconi anemia, complementation group C | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
FANCD2 | Fanconi anemia, complementation group D2 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
FANCG | Fanconi anemia, complementation group G | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FAS | Fas cell surface death receptor | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FBXO11 | F-box protein 11 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
FBXW7 | F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase | Cancer-related genes Predicted secreted proteins
| | | | | Expressed in all |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FH | Fumarate hydratase | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
FLCN | Folliculin | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FLT3 | Fms-related tyrosine kinase 3 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FOXL2 | Forkhead box L2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
GNA11 | Guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
GNAQ | Guanine nucleotide binding protein (G protein), q polypeptide | Cancer-related genes Disease related genes
| | | | | Expressed in all |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
GPC3 | Glypican 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
H3F3A | H3 histone, family 3A | Cancer-related genes
| | | | | Expressed in all |
H3F3B | H3 histone, family 3B (H3.3B) | Cancer-related genes
| | | | | Expressed in all |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HRAS | Harvey rat sarcoma viral oncogene homolog | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
JAK1 | Janus kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
JAK2 | Janus kinase 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
JAK3 | Janus kinase 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KLF4 | Kruppel-like factor 4 (gut) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KLF6 | Kruppel-like factor 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
KMT2D | Lysine (K)-specific methyltransferase 2D | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
KRAS | Kirsten rat sarcoma viral oncogene homolog | Cancer-related genes Disease related genes RAS pathway related proteins
| | | | | Expressed in all |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K4 | Mitogen-activated protein kinase kinase 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MAX | MYC associated factor X | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MEN1 | Multiple endocrine neoplasia I | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MET | Met proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
MLH1 | MutL homolog 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MPL | Myeloproliferative leukemia virus oncogene | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Not detected |